HBM Healthcare Investments

Last updated
HBM Healthcare Investments
Industry Venture capital
Founded 2001
FounderHenri B. Meier
Headquarters Zug, Switzerland
Area served
Worldwide
Owner Publicly listed
Website www.hbmhealthcare.com

HBM Healthcare Investments is a publicly traded (HBMN:SW) Swiss investment and venture capital firm focusing on emerging technologies in the global healthcare sector. Within healthcare their focus is predominantly in biotechnology, medical technology, diagnostics and digital health. [1]

A 2022 article in Swiss daily Luzerner Zeitung profiled HBM and interviewed its CEO, and described the company’s investment strategy as focused on early-stage but post-seed round opportunities. [2]

Founded in July 2001 as HBM Bioventures AG by former Roche Chief Financial Officer Henri B. Meier who was its first Chairperson of the Board. A Handelszeitung article from 2020 described Meier's goal when founding the company as to profit from the "thesis" that from the 2000s onwards "Big Pharma is doing less and less research and development itself and is instead acquiring promising biotech companies" [3] In an analysis of how HBM was put together, Swiss magazine Finanz und Wirtschaft described how he was able to raise almost 500 million Swiss Francs for the company launch. [4] HBM is based in Zug and managed by HBM Partners. [5] HBM acquired rival Swiss VC International BM Biomedicine in 2005. [6] The firm went public on the SIX Swiss exchange in 2008. [7] [8] [9]

HBM invests primarily in U.S., European, Chinese [10] and (on a smaller scale) Indian [11] firms and reported a net asset value of just over 1.5 billion Swiss Francs for end of year 2023. [12] It is often compared by economic-themed media to fellow Swiss healthcare investment firm BB Biotech . [13]

HBM Website

Related Research Articles

Valora is a Swiss retail and food service holding company. The company was acquired on 7 October 2022 by FEMSA.

<span class="mw-page-title-main">Emmi AG</span> Swiss dairy products company

Emmi AG is a Swiss milk processor and dairy products company headquartered in Lucerne. The company employs a total of around 8,900 people in Europe, North America, South America and North Africa (Tunisia). Emmi AG is listed on the SWX Swiss Exchange. The company generates about 42.5 percent of its sales locally and the other 57.5 percent abroad. Numerous production companies in Switzerland belong to the Emmi Group. Outside of Switzerland, Emmi has production facilities, in Chile, Germany, Italy, the Netherlands, Austria, Spain, Tunisia, Brazil, Canada and the USA. Emmi is one of the 500 largest companies in Switzerland.

<span class="mw-page-title-main">Implenia</span> Swiss construction services company

Implenia is a Swiss real estate and construction services company with activities in development and civil engineering in Switzerland and Germany. Implenia is also active in tunneling and related infrastructure construction in Austria, France, Sweden, Norway and Italy. The Group was formed at the beginning of 2006 from the merger of Basel-based Batigroup Holding AG with Geneva-based Zschokke Holding SA. The headquarters are located in Glattpark (Opfikon) in the canton of Zurich. Implenia is one of the 500 largest companies in Switzerland.

Helvetia is an international insurance group that exists since 1858. The group of companies has been organised in a holding structure since 1996. The head office of Helvetia Group is located in St. Gallen, Switzerland.

Werner F.M. De Bondt is one of the founders in the field of behavioral finance. He is also the founding director of Richard H. Driehaus Center for Behavioral Finance at DePaul University in Chicago. Previously, he was the Frank Graner Professor of Investment Management at the University of Wisconsin-Madison, and the Thomas F. Gleed Chair of Business Administration at Albers School of Business and Economics at the Seattle University.

Reichmuth & Co is a Swiss private bank that was founded in Luzern, Switzerland, in 1988. It was the first private bank created in Switzerland in 80 years. Its general partners are Karl Reichmuth, Christof Reichmuth, and Juerg Staub. As of 2012, it was one of 12 unlimited liability bank members listed by the Swiss Private Bankers Association. It is a prominent major player among Swiss hedge funds.

Michael Pieper is a Swiss billionaire businessman, the owner of the kitchen appliance manufacturer Franke, through his Artemis Group holding company. As of October 2021, his net worth was estimated at US$4.8 billion.

<span class="mw-page-title-main">Digitec Galaxus</span> Swiss online retailer

Digitec Galaxus AG is the biggest online retailer in Switzerland. It operates the digitec and Galaxus online shops as well as ten stores in the German and French speaking parts of Switzerland.

Swiss Prime Site AG is one of the largest listed real estate companies in Europe. The fair value of the real estate under management is around CHF 20 billion. The portfolio of the company's own real estate has a value of around CHF 13 billion and consists primarily of commercial and retail properties in the most important Swiss metropolitan regions of the Central Plateau. In addition to the real estate investments, the Group companies Swiss Prime Site Solutions and Jelmoli make up the Services segment.

Ernst Tanner is a Swiss manager and entrepreneur. He is Chairman of the Board of the chocolate manufacturer Lindt & Sprüngli.

Leonteq AG is a Swiss company founded in 2007 and headquartered in Zürich. It is specialized in structured financial products and in insurance products in the sector of finance and technology. It is an issuer of its own products, as well as a partner of other finance companies.

<span class="mw-page-title-main">Dadvan Yousuf</span> Kurdish entrepreneur

Dadvan Ismat Yousuf Yousuf is an Iraqi cryptocurrency investor and businessman whose early bitcoin investments made him the youngest self-made billionaire in Switzerland. Yousuf and his companies have been involved in a number of allegations.

<span class="mw-page-title-main">Daniel Grieder</span> Swiss Entrepreneur and CEO of Hugo Boss

Daniel Grieder is a Swiss entrepreneur and business executive. Between 2014 and 2020 he was CEO of Tommy Hilfiger Global, as well as CEO of PVH Europe and Calvin Klein Europe. Since 2021 he has been CEO of Hugo Boss.

<span class="mw-page-title-main">Rainer Gut</span> Swiss manager (1932–2023)

Rainer Emil Gut was a Swiss bank manager.

<span class="mw-page-title-main">Benjamin Giezendanner</span> Swiss businessman and politician

Benjamin Giezendanner is a Swiss businessman and politician who currently serves as a member of the National Council (Switzerland) for the Swiss People's Party (SVP) since 2019. He previously served on the Grand Council of Aargau being elected as the youngest member only aged 18 in 2001. In the 2023 Swiss federal election he was a candidate for Council of States (Switzerland), but lost election against Marianne Binder-Keller. Giezendanner is the youngest son of former National Councillor Ulrich Giezendanner and brother of incumbent Grand Councillor Stefan Giezendanner.

<span class="mw-page-title-main">Franz Grüter</span>

Franz Josef Grüter is a Swiss businessman and politician. He currently serves as a member of the National Council (Switzerland) for the Swiss People's Party since 30 November 2015. Grüter is also known for founding green.ch group which he ultimately sold to the Altice concern for 214 million Swiss Francs. Grüter belongs among the richest politicians in the Swiss legislative according to Handelszeitung.

<span class="mw-page-title-main">Thomas Matter</span> Swiss businessman, banker, philanthropist and politician

Thomas Matter is a Swiss businessman, banker, philanthropist and politician. He currently serves as a member of the National Council (Switzerland) for the Swiss People's Party since 2014. Matter is estimated to be the second richest politician in the Swiss legislature with an estimated net worth of 150 million Swiss Francs (2017) by Handelszeitung.

Hans Jakob Vontobel was a Swiss private banker and philanthropist. He was the former president of Vontobel between 1984 and 1994 and honorary president until his death. He held approximately 20% of controlling shares of the private bank. He was the patriarch of the Vontobel banking family.

<span class="mw-page-title-main">Bellevue Group</span> Swiss investment management corporation

Bellevue Group AG, headquartered in Küsnacht, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.

<span class="mw-page-title-main">Hochdorf Holding</span> Swiss food company

Hochdorf Holding, often referred to as the Hochdorf Group, is a Swiss food company based in Hochdorf and the third largest dairy company in Switzerland. As of 31 December 2021, the group of companies employed 387 people and generated a consolidated net sales of 303.5 million Swiss francs. Hochdorf Holding is one of the 500 largest companies in Switzerland. Its shares have been listed on the SIX Swiss Exchange since 17. May 2011.

References

  1. ↑ "Aktie der Woche: HBM Healthcare". capital.de (in German). 2018-05-14. Retrieved 2024-01-24.
  2. ↑ Gilb, Christopher (2022-07-22). "Ein gebürtiger Luzerner finanziert die Medikamente der Zukunft". Luzerner Zeitung (in German). Retrieved 2024-01-24.
  3. ↑ "Seine Beteiligungsgesellschaft ist hochrentabel: Henri B. Meiers Geldmaschine heisst HBM". Handelszeitung (in Swiss High German). Retrieved 2024-01-24.
  4. ↑ "Wenn Henri B. Meier ruft kommen 500 Mio. Fr". Finanz und Wirtschaft (in German). 2001-07-04. Retrieved 2024-01-24.
  5. ↑ Brandenberg, Livio (2019-08-17). "Bald 2 Milliarden Wagniskapital in der Schweiz?". Luzerner Zeitung (in German). Retrieved 2024-01-24.
  6. ↑ Staff, P. E. I. (2012-12-30). "HBM bids for rival Swiss life science VC". Private Equity International. Retrieved 2024-01-24.
  7. ↑ "HBM Bioventures wagt endlich den Börsengang". Neue Zürcher Zeitung. 15 January 2008. Retrieved 24 January 2024.
  8. ↑ "HBM Bioventures wants up to 150 mln Sfr from IPO". Reuters. 28 January 2008. Retrieved 24 January 2024.
  9. ↑ Dealbook (2008-01-16). "Swiss Venture Capital Firm Eyes I.P.O." DealBook. Retrieved 2024-01-24.
  10. ↑ "Sequoia China leads $150m series B round for Chinese biotech firm Visen". www.techinasia.com. Retrieved 2024-01-25.
  11. ↑ Konde, Viren (2008-12-02). "Biotechnology business models: An Indian perspective". Journal of Commercial Biotechnology. 15 (3). doi:10.5912/jcb290. ISSN   1478-565X.
  12. ↑ "HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023". markets.businessinsider.com. 2024-01-22. Retrieved 2024-01-24.
  13. ↑ "BB Biotech und HBM – Wer im Biotech-Kasino die Nase vorn hat". Finanz und Wirtschaft (in German). 2023-04-18. Retrieved 2024-01-24.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.